HYPERHIDROSIS is defined as sweating in excess of what is required to regulate body temperature. Affected patients are hampered in occupational and social situations, leading to diminished physical and emotional well-being, difficulty in personal relationships, and social stigmatization.

 

 

Several randomized studies have shown that botulinum toxin type A is a safe, effective, and durable method of treating patients with primary hyperhidrosis. Research demonstrates that when patients who have been unresponsive to topical antiperspirants are injected with botulinum toxin, they experience a 75% reduction in sweating, an improvement in emotional and physical well-being, and a decrease in activity limitations without any serious adverse events.

 

Reduction in symptoms within two weeks of treatment.

Results lasting an average of 6 to 9 months.

High patient satisfaction rate.